[Clinical experiences with the 2-phase preparation Biogest Spofa for hormonal contraception].
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008656:Mestranol / Q000009:adverse effects; D011374:Progesterone / Q000009:adverse effects / Q000031:analogs & derivatives
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D011374:Progesterone; D008656:Mestranol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Klinische Erfahrungen mit dem Zweiphasenpräparat Biogest/Spofa zur hormonalen Kontrazeption